GS-EU-337-1820 - An Observational Drug Utilization Study of Ledipasvir/Sofosbuvir and Tenofovir Disoproxil Fumarate + Pharmacokinetic Enhancer Co-Administration in Adults Co-Infected with Chronic Hepatitis C and HIV-1 Infections (HAVEN co-infection study)

First published 20/07/2016

Last updated 16/02/2024

EU PAS number:

EUPAS14114

Study

Finalised

Documents

Study protocol

Initial protocol

GS-EU-337-1820 Original Protocol 16 March 2016 FINAL

English (600.49 KB - PDF)View document

Study results

GS-EU-337-1820 Annual Progress Report

English (1.31 MB - PDF)View document

Study report

GS-EU-337-1820 Interim Progress Report

English (1.27 MB - PDF)View document

Other information

Secondary tabs